• Explore /
  • Poster
  • / Liquid biopsy using plasma proteomic profiling to reveal predictors of immunotherapy response.

Liquid biopsy using plasma proteomic profiling to reveal predictors of immunotherapy response.

Abstract Poster

Authors

Arnav Mehta

Arnav Mehta

Massachusetts General Hospital, Boston, MA

Arnav Mehta, Gyulnara Kasumova, Marijana Rucevic, Markus Sallman-Almen, Lina Hultin Rosenberg, Michelle S. Kim, David Lieb, Xue Bai, Dennie T. Frederick, Ryan J. Sullivan, Keith Flaherty, Nir Hacohen, Genevieve Marie Boland

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session B

Track

Breast and Gynecologic Cancers,Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Hematologic Malignancies

Sub Track

Biomarkers and Inflammatory Signatures

Citation

J Clin Oncol 37, 2019 (suppl 8; abstr 130)

DOI

10.1200/JCO.2019.37.8_suppl.130

Abstract #

130

Poster Bd #

A4

Abstract Disclosures

Similar Posters

First Author: Mark Chang

First Author: Shipra Gandhi

First Author: Andreas Seeber

Poster

2018 ASCO-SITC Clinical Immuno-Oncology Symposium

Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations.

Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations.

First Author: Laurent Mhanna